BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6138879)

  • 1. [H2-blockers in reflux-esophagitis].
    Berstad A
    Tidsskr Nor Laegeforen; 1983 Jul; 103(19-21):1439-41. PubMed ID: 6138879
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cimetidine and ranitidine in the treatment of reflux esophagitis].
    Kimmig JM
    Z Gastroenterol; 1984 Aug; 22(8):373-8. PubMed ID: 6091353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cimetidine versus ranitidine in the treatment of peptic esophagitis].
    Noya G; Dettori G; Muscas A; Spirito R; Niolu P; Marongiu G; Biglioli P
    Minerva Med; 1983 Apr; 74(14-15):787-90. PubMed ID: 6132354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
    Feldman M; Harford WV; Fisher RS; Sampliner RE; Murray SB; Greski-Rose PA; Jennings DE
    Am J Gastroenterol; 1993 Aug; 88(8):1212-7. PubMed ID: 8101695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of oxmetidine and ranitidine on reflux behavior in patients with esophagitis].
    Weiser HF; Gubernatis G; Siewert JR
    Z Gastroenterol; 1983 Oct; 21(10):580-4. PubMed ID: 6139923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
    Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of roxatidine acetate and ranitidine in the treatment of reflux esophagitis. The Roxatidine Esophagitis Study Group.
    Clin Ther; 1993; 15(2):283-93. PubMed ID: 8100189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between ranitidine and cimetidine in the treatment of reflux oesophagitis.
    Fielding JF; Doyle GD
    Ir Med J; 1984 Nov; 77(11):356-7. PubMed ID: 6096296
    [No Abstract]   [Full Text] [Related]  

  • 10. Cisapride versus ranitidine in the treatment of reflux esophagitis.
    Janisch HD; Hüttemann W; Bouzo MH
    Hepatogastroenterology; 1988 Jun; 35(3):125-7. PubMed ID: 3042576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic achlorhydria: for which diseases, when and for how long?].
    Koop H; Arnold R
    Dtsch Med Wochenschr; 1988 Mar; 113(13):516-8. PubMed ID: 2894969
    [No Abstract]   [Full Text] [Related]  

  • 12. Ranitidine in the management of gastro-oesophageal reflux disease.
    Nelis GF
    Neth J Med; 1985; 28(5):197-200. PubMed ID: 3892319
    [No Abstract]   [Full Text] [Related]  

  • 13. Nocturnal acid breakthrough in children with reflux esophagitis taking proton pump inhibitors.
    Pfefferkorn MD; Croffie JM; Gupta SK; Molleston JP; Eckert GJ; Corkins MR; Fitzgerald JF
    J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):160-5. PubMed ID: 16456408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
    Festen HP; Schenk E; Tan G; Snel P; Nelis F
    Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of reflux esophagitis with H2-blockers, antacids and prokinetic drugs. An analysis of randomized clinical trials.
    Koelz HR
    Scand J Gastroenterol Suppl; 1989; 156():25-36. PubMed ID: 2568015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Our experience in the treatment of reflux esophagitis with histamine H2 receptor antagonists].
    Cappelli J; Morobe J; Van Laethem A; Musin L
    Acta Chir Belg; 1983; 83(6):440-3. PubMed ID: 6318487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ranitidine versus cimetidine in the healing of erosive esophagitis.
    McCarty-Dawson D; Sue SO; Morrill B; Murdock RH
    Clin Ther; 1996; 18(6):1150-60. PubMed ID: 9001831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of ranitidine in the treatment of gastroesophageal reflux and its complications].
    Mainguet P
    Rev Med Suisse Romande; 1995 Oct; 115(10):781-8. PubMed ID: 7501930
    [No Abstract]   [Full Text] [Related]  

  • 19. [Is strong inhibition of gastric acid in the treatment of peptic ulcer sensible?].
    de Bruijne JW; Lamers CB
    Ned Tijdschr Geneeskd; 1989 Apr; 133(13):657-62. PubMed ID: 2566125
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of H2-receptor blockers (cimetidine and ranitidin) on parotid gland secretion and salivary carbonic anhydrase activity in the rat].
    Boros I; Keszler P; Szombath D; Pósch E
    Fogorv Sz; 1993 Aug; 86(8):265-73. PubMed ID: 7902302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.